سعر فيلباستين Velbastine‏ 10مجم فيال للحقن الوريدي 2026

Vinblastine sulfate 10 mg vial for intravenous use (Korea United Pharm; Egyptian agent EIMC).

• Leukopenia is the most common and usually dose-limiting adverse reaction; alopecia, constipation, anorexia, nausea, vomiting and neurological effects (e.g. numbness of digits) are reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated in significant granulocytopenia unless due to the disease being treated, and in the presence of bacterial infection (control infection first).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• For intravenous use only; intrathecal administration is usually fatal. Should be given by individuals experienced in its administration.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Extravasation causes considerable local irritation; stop the injection immediately and give the remainder in another vein.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• CYP3A inhibitors (e.g. erythromycin)May cause earlier onset or increased severity of vinblastine toxicity; enhanced toxicity reported with erythromycin.DailyMed (U.S. National Library of Medicine)
• PhenytoinChemotherapy combinations including vinblastine reduced phenytoin levels and increased seizure activity; monitor levels.DailyMed (U.S. National Library of Medicine)

• Should be given to a pregnant woman only if clearly needed; animal studies suggest teratogenic effects (historical FDA Pregnancy Category D).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Vinblastine sulfate: Binds tubulin and inhibits microtubule formation, arresting cells in metaphase.